Final Program

168 MONDAY • MAY 16
P528
P529
Facilitator:
P530
P531
P532
P533
P534
P535
P536
P537
Facilitator:
P538
P539
P540
An Optimized Viscosity Solution Can Better Preserve
Physiological Lung Function Ex Vivo, During Extended
Ventilation and Perfusion, Prior to Transplantation/J. Cornwell,
S.C. Rowan, K. Rochfort, P. McLoughlin, Dublin, Ireland, p.A3463
Mechanism of Death and Relationship to Systemic and Airway
Inflammation in Brain Dead Organ Donors/E.M. Lowery, M.
Yong, S. Kliethermes, E.J. Kovacs, Maywood, IL, p.A3464
P.M. Shah, MD, Baltimore, MD
Inhibition of Connective Tissue Growth Factor Promotes
Healthy Revascularization and Ameliorates Fibrosis in
Orthotopic Tracheal Transplantation/Y.-C. Lin, X. Jiang, M.
Nicolls, Palo Alto, CA, p.A3465
Domiciliary Non-Invasive Ventilation Post Lung
Transplantation/S. Kotecha, C. Buchan, K. Parker, J. Toghill, B.
Miller, M.T. Naughton, G.I. Snell, E. Dabscheck, Melbourne,
Australia, p.A3466
Long Term Kinetics of CD19+CD24highCD38high Breg Cells in
Lung Transplant Recipients/F. Meloni, M. Morosini, D. Piloni, S.
Magni, A. Balderacchi, L. Scudeller, E. Cova, G.M. Stella, F.
Antonacci, T. Oggionni, Pavia, Italy, p.A3467
Translational Potential for Mass Cytometry in Lung
Transplantation with Limitations from Medicinal Iodine/
B.C. Keller, D.G. Kelley, R.M. Senior, D.E. Byers, J.J. Atkinson, St.
Louis, MO, p.A3468
Carbon Monoxide Modulates Leukocyte
Recruitment/Infiltration in a Murine Orthotopic Single Lung
Transplantation Model of Bronchiolitis Obliterans/Y. Aoki, N.
Walker, D. Pinsky, V. Lama, Ann Arbor, MI, p.A3469
Role of Mitomycin C Application in Lung Transplantation
Related Airway Stenosis/K. Mahmood, M. Elmasri, M.M. Wahidi,
L. Snyder, S.L. Shofer, Durham, NC, p.A3470
Double Trouble: Massive Pulmonary Embolism and Arterial
Stenosis in a Lung Transplant Recipient/J.A. Brenes-Salazar, T.
Behrenbeck, Rochester, MN, p.A3471
Systemic Thrombolysis and Endovascular Clot Retrieval to
Treat Massive PE in Recent Lung Transplant Recipient with
HIT/M. Michaelson, A. Kafi, A. Weinberg, S. Alamro, V. Tapson, D.
Ramzy, S. Ghandehari, G. Chaux, J. Falk, Los Angeles, CA, p.A3472
R.J. Shah, MD, MSCE, San Francisco, CA
Peri-Engraftment Respiratory Distress Syndrome After
Allogeneic Hematopoietic Stem Cell Transplantation
Progressed to Interstitial Lung Fibrosis: A Case Report/P.
Promsin, R. Ruangchira-urai, P. Thomrongpairoj, A. Poompichet, S.
Tongyoo, R. Ratanarat, C. Permpikul, Bangkok, Thailand, p.A3473
Recurrent Shock in Fresh Lung Transplant Patient: History
Solves the Mystery/T. Thaniyavarn, Atlanta, GA, p.A3474
Safe Utilization of Hydrogen Gas in Clinical Setting After Lung
Transplantation/T. Kawamura, J. Yoshida, T. Kimura, S. Funaki,
Y. Shintani, M. Minami, A. Uchiyama, Y. Fujino, A. Nakao, M.
Okumura, Suita, Japan, p.A3475
P541
P542
P543
P544
P545
P546
B42
Pulmonary Allograft Kaposi’s Sarcoma After Lung
Transplantation/S.M. Shadly Ahmed, I. Nizami, W. Saleh, Riyadh,
Saudi Arabia, p.A3476
Expanding Bronchial Cyst as an Indicator of Chronic Lung
Allograft Rejection/P. Mulhall, J. Mamary, G. Criner, Phildelphia,
PA, p.A3477
Donor-Derived Disseminated Toxoplasmosis in Lung
Transplant Recipient /D. Gutteridge, L. Zaffiri, M. Duncan, D.
Roe, C. Hage, Indianapolis, IN, p.A3478
A Case of Tacrolimus Associated Posterior Reversible
Encephalopathy Syndrome (PRES) with Hemorrhage - A Rare
but Major Complication in Post Lung Transplant Patients/K.
Bagavathy, S. Ganesh, Los Angeles, CA, p.A3479
A Case of Fluctuating Mentation in a Lung Transplant
Recipient/K. Walsma, W. Chou, S. Ganesh, R. Barbers, Los
Angeles, CA, p.A3480
Imatinib Protects Against Ischemia-Reperfusion Injury in an Ex
Vivo Rabbit Model of Primary Graft Dysfunction/J.T. Magruder,
J.C. Grimm, L. Johnston, L. Santhanam, R.S. Stephens, D.E.
Berkowitz, M. Damarla, R.L. Damico, P.M. Hassoun, A.S. Shah,
B.S. Kim, Baltimore, MD, p.A3481
THEMATIC POSTER SESSION
COPD: BIOMARKERS
9:00 a.m. - 4:15 p.m. MOSCONE CENTER
Viewing: Posters will be on display for entire session.
Area H, Hall D (North Building, Lower Level)
Discussion: 11:00-11:45: authors will be present for individual discussion
11:45-12:45: authors will be present for discussion with assigned facilitators
Facilitator:
P897
P898
P899
P900
V.M. Pinto-Plata, MD, Boston, MA
The BODE Index and BODE Plus Biomarkers as Predictors of
Long-Term Survival in COPD/N. Locantore, B. Celli, A. Agusti, D.
Lomas, E.K. Silverman, E.F.M. Wouters, H. Coxson, J. Vestbo, L.
Edwards, P.S. Bakke, P.M.A. Calverley, S.I. Rennard, W. MacNee,
B.E. Miller, C. Crim, H. Mullerova, J. Yates, R. Tal-Singer, King of
Prussia, PA, p.A3482
Greater Walking Distance Is Associated with Lower Levels of
Growth Differentiation Factor-15 in COPD: An Analysis of the
COPDGene Cohort/L. Guo, C.M. Freeman, M.J. Budoff, M.T.
Dransfield, M.K. Han, J.E. Hokanson, G.L. Kinney, E.A. Regan,
J.M. Wells, J.L. Curtis, C.H. Martinez, Chengdu, China, p.A3483
Comparison of Oxidant/Antioxidant Balance in COPD and
Non-COPD Smokers/Y. Aydemir, O. Aydemir, A. Sengul, H. Çoban,
A.C. Güngen, C. Tasdemir, H. Duzenli, Sakarya, Turkey, p.A3484
Increased MMP-12 and Decreased Surfactant Protein A in the
Airways of Individuals with COPD - Report from a Bronchoscopy
Investigation Based on the Obstructive Lung Disease in
Northern Sweden (OLIN) Studies/A.F. Behndig, R. Linder, J.
Pourazar, A. Lindberg, A. Blomberg, Umea, Sweden, p.A3485
ATS 2016 • San Francisco